Search

everythinglearnresearchcommunity

for

Search:↓

The mRNA-1273 COVID-19 vaccine may worsen symptoms in people with systemic lupus erythematosus.

A patient experienced severe hair loss after getting an mRNA COVID-19 vaccine.

COVID-19 and vaccines cause various skin reactions and highlight the need for dermatologists in managing these issues and addressing vaccine distribution disparities.

Self-amplifying RNA could be a better option for protein replacement therapy with lower doses and lasting effects, but delivering it into cells is still challenging.

COVID-19 vaccination does not significantly increase the risk of developing alopecia areata.

The SARS-CoV-2 vaccine may be linked to triggering autoimmune conditions like Alopecia Areata.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Long COVID patients may have hormonal imbalances linked to their symptoms.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

Natural compounds, especially Withaferin-A, may help treat post-COVID-19 complications, but some may have side effects.

COVID-19 vaccines do not increase the risk of alopecia areata.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

Some people developed alopecia areata after COVID-19 vaccination, but it's not caused by the vaccine and most improved with treatment.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

COVID-19 vaccines are safe and highly effective for children, with inactivated vaccines being slightly better.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

Non-coding RNAs are important for hair growth and could lead to new hair loss treatments, but more research is needed.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Patients with long COVID after Omicron had fewer hospitalizations and milder symptoms but more fatigue, insomnia, and cough compared to those with Delta.

Most skin reactions to COVID-19 vaccines in India were mild and not a reason to avoid vaccination.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Nirmatrelvir/Ritonavir treatment may lead to a weaker immune response to COVID-19, but doesn't affect the chance of rebound.

Iron deficiency is the main cause of hair loss in women, and iron supplements started within 6 months can improve hair health.

Liposomes show promise for delivering CRISPR for gene editing but face challenges like delivery efficiency and safety concerns.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

Erbium glass laser treatment may help with skin remodeling, reduce inflammation, and improve skin cell maturation.

Hair shaft miR-221 levels can help detect malignant melanoma.